Validity of galactin-3 in acromegaly: comparison with traditional markers
ConclusionIn a summary, this study recommended clinicians measure serum Gal-3 as biomarkers for patients with acromegaly. In addition, the result above shed light on role of Gal-3 on acromegaly pathogenesis and might provide a therapeutic target of acromegaly patients.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Acromegaly | Biomedical Science | General Medicine | Hormones | Insulin | Ireland Health | Laboratory Medicine | Science | Study